Thanks Everyone!
I am another one following all these patient reports with great interest as I have an appointment at the end of January.
I think Ronan's question may be critical: what percentage of patients
do have the genotype bbFF. So far no one has reported having it. It may be true that De Meireir is getting "very good results" giving GcMAF to patients with this genotype--
but, there may be very few patients who have this version of the VDR.
Has anyone seen statistics giving the prevalence of the different genotypes? I may go into the spreadsheet of Yasko patients who have done genotyping and see if I can figure anything out there.
Also, so far I'd guess, most of De Meirleir's patients are not going to be English speaking. So, I found a Dutch forum where some of them are posting. If you use Google Chrome, it will automatically translate each page--very badly!
http://www.mecvs.net/Forum.html
From what I am getting there, XMRV results are just starting to roll into Europe and those who have started GcMAF are traveling to the clinic to get the first 10 infusions by IV. Evidently, he sends patients "from afar" home with frozen GcMAF to take by injection.
All said, we've heard that patients with the "right" genotypes do well, some patients with the "wrong" genotypes respond to a degree, but no statistics. It is good to know that KDM is going to try ARV's on "non-responders."
Let's all keep sharing info--it is hard to get from the "source!"
Best wishes everyone,
Sushi